Journal profile · NEUROSCIENCES
Neuroprotection
ISSN 2770-7296 · eISSN 2770-730X
Neuroprotection: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 4.1 (journal website); fully open access; APC about USD 3,000; median 109 days to acceptance (57 articles, last 24 months); acceptance rate 36% (journal website); 39 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Neuroprotection is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Neuroinflammation and Neurodegeneration Mechanisms, Neurological Disease Mechanisms and Treatments and Diverse Scientific and Economic Studies, together about 25.8% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Neuroprotection publishes work centred around the recent advances and breakthroughs in the fields of neuroprotection and central as well as peripheral nervous system repair. This translational neuroscience journal spans fields including neurobiology, neuropharmacology, neurology, neurosurgery, neuroimaging, neurorehabilitation and basic, as well as translational, neuroscience. We’re excited to contribute to the advancement of next-generation treatments for CNS disorders.
From the journal's Aims & Scope
Research area (LetPub): NEUROSCIENCES
Editor-in-chief Xunming JiPublisher website
Editorial board by country: 37 in mainland China (about 54%); most named Mainland China 37, United States 8, United Kingdom 5, Australia 4, Netherlands 2 (69 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience13.2%
- Neurological Disease Mechanisms and TreatmentsNeuroscience6.8%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.8%
- Human auditory perception and evaluationEngineering5.8%
- Educational Robotics and EngineeringComputer Science5.8%
- Alzheimer's disease research and treatmentsMedicine5.3%
- Neurogenesis and neuroplasticity mechanismsNeuroscience5.3%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceScopusPMCCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 4.1Publisher website ·
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- CiteScore (publisher)
- 3.3Publisher website ·
- CiteScore (publisher) 2025
- 3.3Publisher website ·
- h-index
- 14OpenAlex ·
- i10-index
- 18OpenAlex ·
- 2-year mean citedness
- 3.73OpenAlex ·
- Self-citation rate
- 9.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 25LetPub ·
- Articles per year (publisher) 2025
- 31Publisher website ·
- Downloads per year (publisher) 2025
- 53,974Publisher website ·
Articles by year OpenAlex count · 137 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 40 | 8 |
| 2025 | 39 | 39 | 132 |
| 2024 | 37 | 37 | 293 |
| 2023 | 18 | 18 | 115 |
| 2022 | 3 | 3 | 9 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
109 daysMedian, submission to acceptance · P25–P75 63 days – 168 days
- Acceptance to online
- median 69 days (58 articles)
- Submission to online
- median 195 days
- Sample
- 57 articles with submission and acceptance dates (82 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 36%Publisher website ·
- Acceptance rate (publisher) 2025
- 36%Publisher website ·
- Submission to first decision
- 24 daysPublisher website ·
- Submission to first decision 2025
- 24 daysPublisher website ·
- Submission to acceptance 2025
- 91 daysPublisher website ·
- Acceptance to publication 2025
- 69 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,534 / GBP 2,281 / USD 3,000 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 3,000 / EUR 2,534 / GBP 2,281 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Keywords
- 3–5
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted9, with length limits
- case reportg the main content of the article. (10) Case Report Word limit: 1500 words maximum but excluding abstract, references, tables and figumain text ≤ 1,500 words
- commentaryng the main content of the article (11) Commentary Word limit: 1500 words maximum but excluding references, tables and figures. Abstrmain text ≤ 1,500 words
- editorials, as well as bibliometric reviews. (1) Editorial Word limit: 2000 words maximum but excluding references, tables and figures. Abstrmain text ≤ 2,000 words
- guidelineGuideline articles introduce or discuss evidence-based recommendations for clinical or experimental research.Length not stated
- letter to the editorLetter to the EditorLength not stated
- meta-analysisng the main content of the article. (5) Meta-Analysis Word limit: 5,000 words maximum excluding abstract, references, tables, and figuresmain text ≤ 5,000 words
- original articleing the main content of the article (6) Original Article Word limit: 4000 words maximum including abstract but excluding references, tablesmain text ≤ 4,000 words
- protocolmain content of the article. (7) Study Protocols Word limit: 5000 words maximum but excluding abstract, references, tables and figumain text ≤ 5,000 words
- reviewng the main content of the article. (3) Review Word Limit: 10000 words maximum including abstract but excluding references, tablesmain text ≤ 10,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Trial registration / reporting guidelines
- Authorship Authorship and Acknowledgements
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:i. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;ii. Drafting the work or revising it critically for important…
Source ↗Publisher website ·- Conflicts of interest Disclosure
Articles are required to include a disclosure statement. Disclosure normally includes three sessions: Conflict of Interests, Ethical Statement and Author Contribution.Conflict of Interests: The statement should disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manusc…
Source ↗Publisher website ·- Data availability Data Availability
Encourages data sharing Model summary
This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- Publication ethics Publication Ethics
Follows COPE core practices Model summary
This journal follows the core practices of the Committee on Publication Ethics (COPE) and handles cases of research and publication misconduct accordingly (https://publicationethics.org/core-practices). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wi…
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ at http://exchanges.wiley.com/authors/faqs---copyright-terms--conditions_301.html
Source ↗Publisher website ·- Open access
Open Access Model summary
Neuroprotection is an Open Access journal that all content is freely available without charge to the user or his/her institution.
Source ↗Publisher website ·- Peer review Review Process
Single-blind peer review Model summary
Neuroprotection uses a single-blind peer-review process. Submitted manuscripts will generally be externally peer-reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on th…
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck for plagiarism detection Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2770-7296
- Electronic ISSN
- 2770-730X
- Society / sponsor
- Chinese Medical Association
- Latest issue on the website
- Volume 4, Issue 3 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Neuroprotection
What CAS zone is Neuroprotection in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Neuroprotection?
The journal's website gives an impact factor of 4.1 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 14.
How long does peer review take at Neuroprotection?
Based on the dates recorded on 57 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 109 days (interquartile range 63–168 days); the journal's website gives an acceptance rate of 36% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Neuroprotection?
According to the journal's author guidelines: Keywords: 3–5; Reference style: AMA; First submission: Free format: the journal's layout is not required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Neuroprotection based?
Of the 69 board members whose country the journal's board page names, 37 (about 54%) are in mainland China; the countries named most often are Mainland China (37), United States (8) and United Kingdom (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Neuroprotection?
According to LetPub and DOAJ records, Neuroprotection is indexed in ESCI and DOAJ. The journal's website also lists Web of Science, Scopus, PMC and CAS; that list has not been checked against each database.
Is Neuroprotection open access, and what is the APC?
Neuroprotection is a fully open-access journal. APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .